Status:
TERMINATED
High-dose Vitamin D3 in Pancreas Cancer
Lead Sponsor:
Medical University of Graz
Conditions:
Pancreas Cancer
Vitamin D Deficiency
Eligibility:
All Genders
18-99 years
Phase:
PHASE3
Brief Summary
Different studies have shown that a deficiency in vitamin D (≤20ng/mL) results in higher rates in morbidity and mortality rates in cancer patients. Clinical studies investigated and demonstrated alter...
Eligibility Criteria
Inclusion
- both sexes
- vitamin D deficiency(≤20ng/ml)
- patients\>18 years of age
- pancreatic cancer
- surgical intervention/non-surgical intervention
- signed written informed consent
Exclusion
- patients\<18 years of age
- pregnancy
- contraindication for oral vitamin D intake
- hypercalcemia (\> 2.65 mmol/l total calcium and/or \> 1.35 mmol/l ionized calcium at screening)
- other ongoing vitamin D conducted trial
- known kidney stones, active tuberculosis or sarcoidosis (in the last 12 months)
- metastasized pancreatic cancer
- normal vitamin D serum levels
- missing written informed consent
Key Trial Info
Start Date :
April 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 20 2021
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT03472833
Start Date
April 1 2018
End Date
April 20 2021
Last Update
February 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Graz
Graz, Styria, Austria, 8010